Botfet / Company detail

AMPH

universe

Amphastar Pharmaceuticals, Inc.

biotech

Moat score60out of 100

The numbers

Financial metrics

Quality gate and thesis context

Roic7.5%

Gross Margin49.5%

Revenue Cagr13.2%

Fcf Conversion123.6%

Fcf Yield11.2%

Interest Coverage8.3x

Market Cap B$1.1B

Pe14.4

Quality PassPass

Founder LedNo

Thesis AlignedYes

Moat Quant60

Why it may endure

Moat breakdown

Quant: 60 · Curator: 0

Market Share Stability12

Network Effects6

Pricing Power20

Regulatory Moat16

Switching Costs6

Conviction0/10

Leadership0/10

Vision0/10

← Back to the full screener